Clinical Trial Update: AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating AZD6244 (selumetinib) and sorafenib in advanced hepatocellular carcinoma was terminated (Phase 1/Phase 2) according to the registry up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AZD6244 (selumetinib)
• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: TERMINATED